Ledger.Open graph →
SEC Form D · filed June 14, 2016

Aclaris Therapeutics, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Christopher A. Molineaux · Malvern, PADirectorChristopher Powala · MALVERN, PAExecAnand A. Mehra · Malvern, PADirectorAlbert A. Cha · Malvern, PADirectorFrank Ruffo · MALVERN, PAExecAlbert A. Cha · Malvern, PADirectorRichard A. Bierly · MALVERN, PADirectorNeal Walker · Phoenixville, PAExec · DirectorNeal Walker · Wayne, PAExec · DirectorRichard A. Bierly · MALVERN, PADirectorFrank Ruffo · MALVERN, PAExecStuart Shanler · MALVERN, PAExecStuart Shanler · MALVERN, PAExecChristopher Powala · Wayne, PAExecKamil Ali-Jackson · Malvern, PAExecSteven A. Tullman · MALVERN, PADirectorAnand A. Mehra · Malvern, PADirectorChristopher A. Molineaux · Malvern, PADirectorSteven A. Tullman · MALVERN, PADirectorKamil Ali-Jackson · MALVERN, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗